Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Controlled and Blinded Assessment Study of the Efficacy of MOOV Head Lice Treatment (Ego Pharmaceutical Pty. Ltd.) in the Treatment of Head Lice in Primary School Children.

NCT00381082 is registered in ClinicalTrials.gov with Uniquest Pty Ltd as lead sponsor.

NCT NCT00381082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00381082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Controlled and Blinded Assessment Study of the Efficacy of MOOV Head Lice Treatment (Ego Pharmaceutical Pty. Ltd.) in the Treatment of Head Lice in Primary School Children.
Lead sponsor
Uniquest Pty Ltd
Phase
Phase 2/3
Overall status
Completed
Start date
September 30, 2004
Completion date
November 30, 2004
Enrollment
152
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pediculosis